Literature DB >> 22858083

Proteomic profiling implies mitochondrial dysfunction in tachycardia-induced heart failure.

Christoph Birner1, Alexander Dietl, Rainer Deutzmann, Josef Schröder, Peter Schmid, Carsten Jungbauer, Markus Resch, Dierk Endemann, Klaus Stark, Günter Riegger, Andreas Luchner.   

Abstract

BACKGROUND/
OBJECTIVES: Molecular mechanisms of congestive heart failure as reflected by alterations of protein expression patterns are still incompletely analyzed. We therefore investigated intraventricular (ie, left ventricular congestive heart failure [LV-CHF] vs. LV-control [CTRL], and right ventricular [RV]-CHF vs. RV-CTRL) and interventricular (ie, LV-CHF vs. RV-CHF, and LV-CTRL vs. RV-CTRL) protein expression differences in an animal model.
METHODS: The model of rapid ventricular pacing in rabbits was combined with a proteomic approach using 2-dimensional gel electrophoresis. Identification of proteins was done by matrix-assisted laser desorption/ionization-tandem mass spectrometry (MALDI-MS/MS).
RESULTS: Rapid ventricular pacing-induced heart failure was characterized by LV dilatation, dysfunction, and hypotension as well as by increased BNP gene expression. By comparing LV-CHF vs. LV-CTRL, proteins were found to be underexpressed at 3 crucial points of cellular energy metabolism. In RV-CHF vs. RV-CTRL, proteins belonging to respiratory chain complexes were underexpressed, but additionally a disturbance in the nitric oxide-generating enzymatic apparatus was seen. Regarding the interventricular analyses, a stronger expression of energetic pathways was accompanied by an underexpression of contractile and stress response proteins in failing left vs. right ventricles. Finally, significant protein expression differences were found in LV-CTRL vs. RV-CTRL reflecting a higher expression of contractile, stress response, and respiratory chain proteins in LV tissue.
CONCLUSIONS: In tachycardia-induced heart failure, significant inter- and intraventricular protein expression patterns were found with a predominance of proteins, which are involved in cellular energy metabolism.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22858083     DOI: 10.1016/j.cardfail.2012.06.418

Source DB:  PubMed          Journal:  J Card Fail        ISSN: 1071-9164            Impact factor:   5.712


  14 in total

1.  Right ventricular protein expression profile in end-stage heart failure.

Authors:  Yan Ru Su; Manuel Chiusa; Evan Brittain; Anna R Hemnes; Tarek S Absi; Chee Chew Lim; Thomas G Di Salvo
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

2.  Antihypertrophic effects of combined inhibition of the renin-angiotensin system (RAS) and neutral endopeptidase (NEP) in progressive, tachycardia-induced experimental heart failure.

Authors:  Christoph Birner; Coskun Ulucan; Mona Bratfisch; Tobias Götz; Alexander Dietl; Frank Schweda; Günter A Riegger; Andreas Luchner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-08-16       Impact factor: 3.000

Review 3.  Targeting Mitochondrial Calcium Handling and Reactive Oxygen Species in Heart Failure.

Authors:  Alexander Dietl; Christoph Maack
Journal:  Curr Heart Fail Rep       Date:  2017-08

4.  Derangements and Reversibility of Energy Metabolism in Failing Hearts Resulting from Volume Overload: Transcriptomics and Metabolomics Analyses.

Authors:  Ying-Chang Tung; Mei-Ling Cheng; Lung-Sheng Wu; Hsiang-Yu Tang; Cheng-Yu Huang; Gwo-Jyh Chang; Chi-Jen Chang
Journal:  Int J Mol Sci       Date:  2022-06-18       Impact factor: 6.208

5.  Mitochondrial proteome remodeling in ischemic heart failure.

Authors:  Tingting Liu; Le Chen; Eunjung Kim; Diana Tran; Brett S Phinney; Anne A Knowlton
Journal:  Life Sci       Date:  2014-02-16       Impact factor: 5.037

6.  Metabolic remodeling in moderate synchronous versus dyssynchronous pacing-induced heart failure: integrated metabolomics and proteomics study.

Authors:  Junko Shibayama; Tatiana N Yuzyuk; James Cox; Aman Makaju; Mickey Miller; Justin Lichter; Hui Li; Jane D Leavy; Sarah Franklin; Alexey V Zaitsev
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

7.  NT-proBNP Predicts Cardiovascular Death in the General Population Independent of Left Ventricular Mass and Function: Insights from a Large Population-Based Study with Long-Term Follow-Up.

Authors:  Alexander Dietl; Klaus Stark; Martina E Zimmermann; Christa Meisinger; Heribert Schunkert; Christoph Birner; Lars S Maier; Annette Peters; Iris M Heid; Andreas Luchner
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

8.  Combined Inhibition of the Renin-Angiotensin System and Neprilysin Positively Influences Complex Mitochondrial Adaptations in Progressive Experimental Heart Failure.

Authors:  Laura Grois; Julian Hupf; Jörg Reinders; Josef Schröder; Alexander Dietl; Peter M Schmid; Carsten Jungbauer; Markus Resch; Lars S Maier; Andreas Luchner; Christoph Birner
Journal:  PLoS One       Date:  2017-01-11       Impact factor: 3.240

9.  3D vena contracta area after MitraClip© procedure: precise quantification of residual mitral regurgitation and identification of prognostic information.

Authors:  Alexander Dietl; Christine Prieschenk; Franziska Eckert; Christoph Birner; Andreas Luchner; Lars S Maier; Stefan Buchner
Journal:  Cardiovasc Ultrasound       Date:  2018-01-09       Impact factor: 2.062

10.  Low T3 State Is Correlated with Cardiac Mitochondrial Impairments after Ischemia Reperfusion Injury: Evidence from a Proteomic Approach.

Authors:  Francesca Forini; Nadia Ucciferri; Claudia Kusmic; Giuseppina Nicolini; Antonella Cecchettini; Silvia Rocchiccioli; Lorenzo Citti; Giorgio Iervasi
Journal:  Int J Mol Sci       Date:  2015-11-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.